Acadia Healthcare Company, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B | $2.09B | $2.01B | $1.90B |
| Acute Inpatient Psychiatric Facilities | $1.83B | $1.68B | $1.49B | — | — | — | — | — |
| Specialty Treatment Facilities | $567.2M | $592.0M | $614.2M | — | — | — | — | — |
| Comprehensive Treatment Centers | $567.2M | $537.9M | $500.2M | — | — | — | — | — |
| Residential Treatment Centers | $348.1M | $345.8M | $325.0M | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $177.6M | $156.8M | $153.3M | $124.3M | $108.2M | $97.8M | $90.4M | $86.6M |
| Operating Income | $-1.07B | $341.9M | $-25.4M | $374.1M | $275.8M | $183.8M | $585.9M | $593.6M |
| Operating Margin | -32.2% | 10.8% | -0.9% | 14.3% | 11.9% | 8.8% | 29.2% | 31.2% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-1.07B | $341.9M | $-25.4M | $374.1M | $275.8M | $183.8M | $78.4M | $67.4M |
| Income Tax Expense | $26.0M | $77.4M | $-9.7M | $94.1M | $67.6M | $40.6M | $25.1M | $9.9M |
| Net Income | $-1.10B | $255.6M | $-21.7M | $273.1M | $190.6M | $-672.1M | $108.9M | $-175.8M |
| Net Margin | -33.3% | 8.1% | -0.7% | 10.5% | 8.2% | -32.2% | 5.4% | -9.2% |
| EPS (Basic) | $-12.16 | $2.79 | $-0.24 | $3.05 | $2.15 | $-7.65 | $1.24 | $-2.01 |
| EPS (Diluted) | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 | $-7.59 | $1.24 | $-2.01 |
| Shares Outstanding (Basic) | 90.7M | 91.6M | 90.9M | 89.7M | 88.8M | 87.9M | 87.6M | 87.3M |
| Shares Outstanding (Diluted) | 90.7M | 92.1M | 90.9M | 91.6M | 90.8M | 88.6M | 87.8M | 87.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |